Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Celltrion (068270) – CT-P55 (Cosentyx Biosimilar) U.S. BLA Submission / 2026-07-30 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Matters Related to Sustainability Report (Voluntary Disclosure) / 2026-06-30 Disclosures
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for ALT-B4 / 2026-01-20 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Decision on Loan to Others / 2025-09-10 Disclosures
  • [Disclosure] Samsung Biologics (207940) – (Correction) Major Management Matters Related to Investment Decisions / 2024-12-19 Disclosures
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Capacity Pre-Bookings · Pricing Power · Shareholder Returns / 2025-10-29 RESEARCH
  • [Disclosure] Jeju Semiconductor (080220) – Resolution on Convening of General Meeting of Shareholders / 2025-02-26 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Outlook on Operating Results Based on Consolidated Financial Statements (Fair Disclosure) / 2025-01-22 Disclosures

[Disclosure] ISU PETASYS (007660) – Investor Relations (IR) Announcement / 2024-02-28

Posted on February 28, 2024August 1, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

ISU PETASYS is participating in the Citi Korea Investors Conference in Yeouido, Seoul, holding one-on-one and small group meetings with major domestic and foreign institutional investors to present its key business status.

📊 [Key Disclosure Details & Financial Summary]

  1. Date & Time: March 07, 2024 (13:00 – 17:00)
  2. Location: Yeouido, Seoul
  3. Target Audience: Major domestic and foreign institutional investors
  4. Purpose: Participation in the Citi Korea Investors Conference
  5. Method: One-on-One and Small Group Meetings
  6. Sponsor: Citi Securities
  7. Key Agenda: Overview of key business status and Q&A session
  8. IR Presentation Materials:
  • Posting Date: March 07, 2024
  • Official Website: http://www.petasys.com

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Participation in Institutional Investors Conference and IR Presentation Material Verification

The company is participating in an IR event to share its business status with major institutional investors. Reviewing the presentation contents and officially published materials is important to understand the company’s operational updates. Relevant presentation files can be tracked through the official IR materials scheduled for release on the company’s website on March 07, 2024.

📢 Disclaimer & Source Notice

Source: This content has been newly structured and created based on official filing data from the Financial Supervisory Service DART system.

Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific securities. All investment decisions and financial liabilities rest entirely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Semiconductors, Disclosures

Post navigation

Previous Post: [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2024-02-28
Next Post: [Disclosure] Samsung Biologics (207940) – (Correction) Submission of Audit Report / 2024-02-28

Related Posts

  • [Disclosure] KEPCO (015760 / KEP) – (Correction) Results of Extraordinary General Meeting of Shareholders / 2025-01-07 Disclosures
  • [Disclosure] ALTEOGEN (196170) – Trading Suspension and Resumption of Stock Futures and Options / 2026-07-16 Disclosures
  • [Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Presentation / 2025-02-14 Semiconductors
  • [Disclosure] Celltrion (068270) – Decision on Paid-in Capital Increase by Subsidiary (Correction) / 2026-05-11 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Other Management Matters (Voluntary Disclosure) / 2024-06-21 Disclosures
  • [Disclosure] Hanwha Systems (272210) – (Correction) Decision on Paid-in Capital Increase / 2025-12-23 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Resumption of Production / 2024-02-14 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Provisional Performance (Consolidated Financial Results) / 2024-01-24 Disclosures
  • [Disclosure] SK Hynix (000660 / SKHY) – Decision on Capital Increase / 2026-06-24 Semiconductors
  • [Disclosure] Celltrion (068270) – CHMP Positive Opinion Granted for CT-P39 (Xolair Biosimilar) by EMA / 2024-03-25 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Advance Notice of Financial Results Announcement / 2025-07-09 Disclosures
  • [Disclosure] Daeduck Electronics (353200) – Decision on Cash/In-Kind Dividend / 2025-02-20 Semiconductors
  • [Disclosure] Hanwha Aerospace (012450) – Decision on Acquisition of Shares and Investment Certificates of Other Corporations / 2024-03-26 Disclosures
  • [Disclosure] Hyundai Motor (005380) – (Corrected) Decision on Acquisition of Shares and Investment Securities in Other Corporation (Voluntary Disclosure) / 2026-05-21 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme